References
- Okuda K. Hepatocellular carcinoma. J Hepatol, 2000, 32: 22537.
- Parkin D. M., Bray F., Ferlay J., Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer, 2001, 94: 153–6.
- Verhoef C., Visser O., de Man R. A., de Wilt J. H. W., Ijzermans J. N. M., Janssen-Heijnen M. L. G. L. HCC in the Netherlands: incidence treatment and survival patterns. EJC, 2004, 40: 1530–8.
- Hussain S. M., Semelka R. C., Mitchell D. G. MR imaging of hepatocellular carcinoma. Magn Reson Imaging Clin N Am, 2002, 10: 31–52.
- Poon R. T., Fan S. T., O’Suilleabhain C. B., Wong J. Aggressive management of patients with extrahepatic and intrahepatic recurrences of hepatocellular carcinoma by combined resection and locoregional therapy. J Am Coll Surg, 2002, 195: 311–8.
- Tung-Ping Poon R., Fan S. T., Wong J. Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg, 2000, 232: 10–24.
- Arii S, Monden K., Niwano M. et al. Results of surgical treatment for recurrent hepatocellular carcinoma; comparison of outcome among patients with multicentric carcinogenesis, intrahepatic metastasis, and extrahepatic recurrence. J Hepatobiliary Pancreat Surg, 1998, 5: 86–92.
- Sugimachi K., Maehara S., Tanaka S., Shimada M. Repeat hepa-tectomy is the most useful treatment for recurrent hepatocellular carcinoma. J Hepatobiliary Pancreat Surg, 2001, 8: 410–6.
- Arii S., Teramoto K., Kawamura T. et al. Characteristics of recurrent hepatocellular carcinoma in Japan and our surgical experience. J Hepatobiliary Pancreat Surg, 2001, 8: 397–403.
- Farges O., Regimbeau J. M., Belghiti J. Aggressive management of recurrence following surgical resection of hepatocellular carcinoma. Hepatogastroenterology, 1998, 45: 1275–80.
- Chen W. T., Chau G. Y., Lui W. Y. et al. Recurrent hepatocellular carcinoma after hepatic resection: prognostic factors and longterm outcome. EJSO, 2004, 30: 414–20.
- Verhoef C., de Man R. A., Zondervan P. E., Tilanus H. W., IJzermans J. N. M. Good outcomes after resection of large hepa-tocellular carcinoma in the non-cirrhotic liver. Dig Surg, 2004, 21: 380–6.
- Lang H., Sotiropoulos G. C., Doemland M. et al. Liver resection for hepatocellular carcinoma in non-cirrhotic liver without underlying viral hepatitis. Br J Surg, 2005, 92: 198–202.
- Nagasue N., Ono T., Yamanoi A. et al. Prognostic factors and survival after hepatic resection for hepatocellular carcinoma without cirrhosis. Br J Surg, 2001, 88: 515–22.
- Fong Y., Sun R. L., Jarnagin W. et al. An analysis of 412 cases of hepatocellular carcinoma at a western centre. Ann Surg, 1999, 229: 790–800.
- Schwartz J. D., Schwartz M., Mandeli J., Sung M. Neoadjuvant and adjuvant therapy for resectable hepatocellular carcinoma: review of the randomised clinical trials. Lancet Oncol, 2002, 3: 593–603.
- Okasaka T., Okada S., Ishii H. et al. Prognosis of hepatocellular carcinoma patients with extrahepatic metastases. Hepatogastro-enterology 1997, 44: 251–7.
- Schwartz J. D., Beutler A. S. Therapy for unresectable hepatocellular carcinoma: review of the randomized clinical trials-II: systemic and local non-embolization-based therapies in un-resectable and advanced hepatocellular carcinoma. Anti-Cancer Drugs, 2004, 15: 439–52.
- Gambarin-Gelwan M., Wolf D. C., Shapiro R., Schwartz M. E., Min A. D. Sensitivity of commonly available screening tests in detecting hepatocellular carcinoma in cirrhotic patients undergoing liver transplantation. Am J Gastroenterol, 2000, 95: 1535–8.
- Di Bisceglie A. M., Hoofnagle J. H. Elevations in serum alpha-fetoprotein levels in patients with chronic hepatitis B. Cancer, 1989, 64: 2117–20.
- Verhoef C., Valkema R. A., de Man R. A. et al. Fluorine-18 FDG imaging in hepatocellular carcinoma using positron coincidence detection and single photon emission computed tomography. Liver, 2002, 22: 51–6.
- Sharlene A. Teefey, Charles C. et al Detection of Primary Hepatic Malignancy in Liver Transplant Candidates: Prospective Comparison of CT, MR Imaging, US, and PET. Radiology, 2003, 126: 533–42.
- Hain S. F., Fogelman I. Recent advances in imaging hepato-cellular carcinoma: diagnosis, staging and response assessment: functional imaging. Cancer J, 2004, 10: 121–7.
- Sugiyama M., Sakahara H., Torizuka T. et al. 18F-FDG PET in the detection of extrahepatic metastases from hepatocellular carcinoma. J Gastroenterol, 2004, 39: 961–8.
- Lo C. M., Lai E. C., Fan S. T., Choi T. K., Wong J. Resection for extrahepatic recurrence of hepatocellular carcinoma. Br J Surg, 1994, 81: 1019–21.
- Lam C. M., Lo C. M., Yuen W. K. et al. Prolonged survival in selected patients following surgical resection for pulmonary metastasis from hepatocellular carcinoma. Br J Surg, 1998, 85: 1198–1200.
- Shuto T., Hirohashi K., Kubo S. et al. Treatment of adrenal metastases after hepatic resection of a hepatocellular carcinoma. Dig Surg, 2001, 18: 294–7.
- Momoi H., Shimahara Y., Terajima H. et al. Management of adrenal metastasis from hepatocellular carcinoma. Surg Today, 2002, 32: 1035–41.
- Chang L., Chen Y. L., Kao M. C. Intracranial metastasis of hepa-tocellular carcinoma: review of 45 cases. Surg Neurol, 2004, 62: 172–7.
- Kwak G. Y., Jung J. O., Sung S. W., Lee H. S. Long-term survival after pulmonary metastectomy of hepatocellular carcinoma; treatment outcome or natural history. Hepatogastroenterology, 2004, 51: 1428–33.